NRW
NVCR icon

Nova R Wealth’s NovoCure NVCR Stock Holding History

Nova R Wealth’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-300
Closed -$12.4K – 60
2023
Q2 		$12.4K Buy
+300
New +$18.6K 0.01% 64
2023
Q1 		– Sell
-700
Closed -$51.3K – 77
2022
Q4 		$51.3K Buy
+700
New +$52.7K 0.04% 71
2022
Q1 		– Sell
-3,900
Closed -$245K – 83
2021
Q4 		$245K Buy
+3,900
New +$391K 0.2% 67

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Nova R Wealth's NVCR Position: Q3 2023 in Review

Nova R Wealth sold out of NovoCure (NVCR) in Q3 2023, closing a stake of 6,761 shares — an estimated $281K sold.

Nova R Wealth first reported a position in NVCR in Q4 2021 and held it in 7 quarters. The position peaked at $575K in Q1 2022. 226 funds tracked by Wall St. Rank hold NVCR as of Q3 2023.

  • Nova R Wealth reported no remaining NovoCure position as of Q3 2023 after selling out during the quarter.
  • Nova R Wealth sold 6,761 NovoCure shares in Q3 2023, an estimated $281K.
  • Nova R Wealth first reported a position in NovoCure in Q4 2021 and held it in 7 quarters.
  • Nova R Wealth's NovoCure position peaked at $575K in Q1 2022.
  • 226 funds tracked by Wall St. Rank held NovoCure as of Q3 2023.

Based on Nova R Wealth's 13F filing for Q3 2023, filed 19 Oct 2023.